Low abundance in the context of cancer refers to the presence of certain molecules, such as proteins, RNAs, or genetic mutations, in very small quantities within a biological sample. The detection and study of these low-abundance molecules are crucial for understanding the complexities of cancer biology, including early diagnosis, progression, and treatment responses.
